Answers are grounded in this paper and cite their sources.
Cohort study evaluates post-acute complications and health-care utilization in nonhospitalized individuals with SARS-CoV-2, highlighting outpatient recovery outcomes.
Background Individuals admitted to hospital for COVID-19 might have persisting symptoms (so-called long COVID) and delayed complications after discharge. However, little is known regarding the risk for those not admitted to hospital. We therefore examined prescription drug and health-care use after SARS-CoV-2 infection not requiring hospital admission.
No takes yet. Share an insight, caveat, or question.
Lund et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: